Re-starting or initiating guideline-recommended hypoglycemic agents for patients admitted with hyperglycemic crisis.

Saved in:
Bibliographic Details
Title: Re-starting or initiating guideline-recommended hypoglycemic agents for patients admitted with hyperglycemic crisis.
Authors: Alshaya AI; Department of Pharmaceutical Care Services, King Abdulaziz Medical City, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Al-Yahya H; Department of Pharmaceutical Care Services, King Abdulaziz Medical City, Riyadh, Saudi Arabia., Alshehri A; Department of Pharmaceutical Care Services, King Abdulaziz Medical City, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Alrashed M; Department of Pharmaceutical Care Services, King Abdulaziz Medical City, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Alshaya O; Department of Pharmaceutical Care Services, King Abdulaziz Medical City, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Alfehaid L; Department of Pharmaceutical Care Services, King Abdulaziz Medical City, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Badreldin HA; Department of Pharmaceutical Care Services, King Abdulaziz Medical City, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Source: Frontiers in medicine [Front Med (Lausanne)] 2025 Aug 18; Vol. 12, pp. 1485357. Date of Electronic Publication: 2025 Aug 18 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2296-858X
DOI:10.3389/fmed.2025.1485357